Risk factors

International operations across multiple foreign countries create complex regulatory, tax, and currency exposure risks. Storage facility capacity constraints limit vehicle acceptance after adverse weather events. Proprietary technology reliance exposes the company to intellectual property and operational disruption risks.

Franklin Wireless faces operational risks including sole-source component reliance, potential software and hardware defects, and international tariff exposure.

InMed Pharmaceuticals faces early-stage clinical trial risks and Nasdaq delisting threats due to minimum bid price requirements. The company relies heavily on its proprietary IntegraSyn manufacturing approach and EB disease indications. Regulatory approval processes across the FDA, HC, and EMA remain lengthy and uncertain.

Clinical-stage biopharmaceutical company focused on cannabinoid and psychedelic drug candidates with a going concern warning. Relies heavily on Australian R&D tax incentives and requires ongoing external funding. Subject to strict controlled substance laws and potential public controversy.

Marine Petroleum Trust relies entirely on underlying oil and gas leases operated by third parties without control or ability to expand interests.

Neuphoria Therapeutics faces typical clinical-stage biotechnology risks centered on cash burn, clinical trial execution, regulatory approval, and third-party manufacturing dependencies.

Precision Optics faces significant risks from reliance on single-source suppliers in China, a small customer base, and ongoing financial losses requiring capital raises.

Palatin Technologies faces severe going concern doubts, relying heavily on additional financing to complete clinical trials for its melanocortin receptor agonists. The company sustained a net loss of $29.7 million for fiscal 2024, bringing its accumulated deficit to $441.8 million. Operations depend entirely on third-party contract manufacturers and research organizations for product supply and trial execution.

Substantial doubt about going concern with $200,013 cash and $38.0 million accumulated deficit.

ReposiTrak relies heavily on subscription-based compliance and food safety solutions connected through its Hubs and Spokes model. Business growth and revenue depend heavily on customer adoption and compliance deadlines related to FSMA 204. Operations face litigation risks stemming from product recalls, system failures, and third-party data center interruptions.

Top five clients generated 49.8% of fiscal 2024 revenue, creating high customer concentration risk. Shareholders equity had a $1.9 million deficit, raising going concern doubts. Operations depend heavily on international delivery sites in India and Mexico.

The company relies heavily on a single retail and decorative fixture distribution facility in Lebanon, Tennessee. Billboard advertising restrictions heavily impact customer traffic along interstate highways. A strategic transformation plan aims to enhance menus and retail offerings to improve margins.